TYROBP and diabetes mellitus: CETP, TYROBP, and SECTM1 are integral biomarkers in the pathogenesis of DM–TB, exerting a coordinated influence on disease progression and severity through their effects on lipid metabolism, immune cell activation, and IFN-γ production.